Processa Pharmaceuticals Inc (PCSA)
2.43
+0.81
(+50.00%)
USD |
NASDAQ |
Apr 25, 16:00
2.16
-0.27
(-11.11%)
Pre-Market: 08:50
Processa Pharmaceuticals Shareholders Equity (Quarterly): 4.989M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 4.989M |
| September 30, 2023 | 7.168M |
| June 30, 2023 | 9.160M |
| March 31, 2023 | 10.14M |
| December 31, 2022 | 7.471M |
| September 30, 2022 | 17.24M |
| June 30, 2022 | 20.08M |
| March 31, 2022 | 23.24M |
| December 31, 2021 | 25.49M |
| September 30, 2021 | 27.21M |
| June 30, 2021 | 29.24M |
| March 31, 2021 | 31.34M |
| December 31, 2020 | 22.94M |
| September 30, 2020 | 5.527M |
| June 30, 2020 | 6.593M |
| March 31, 2020 | 7.234M |
| December 31, 2019 | 8.012M |
| September 30, 2019 | 8.671M |
| June 30, 2019 | 8.502M |
| March 31, 2019 | 9.124M |
| December 31, 2018 | 9.701M |
| September 30, 2018 | 10.51M |
| June 30, 2018 | 11.31M |
| Date | Value |
|---|---|
| March 31, 2018 | 7.276M |
| December 31, 2017 | 0.3732M |
| September 30, 2017 | -0.0351M |
| June 30, 2017 | -2.491M |
| March 31, 2017 | -2.437M |
| December 31, 2016 | -2.351M |
| September 30, 2016 | -2.250M |
| June 30, 2016 | -2.170M |
| March 31, 2016 | -2.118M |
| December 31, 2015 | -1.979M |
| September 30, 2015 | -1.618M |
| June 30, 2015 | -1.320M |
| March 31, 2015 | 0.7018M |
| December 31, 2014 | 1.208M |
| September 30, 2014 | -0.1168M |
| June 30, 2014 | 0.623M |
| March 31, 2014 | 1.030M |
| December 31, 2013 | 1.671M |
| September 30, 2013 | 2.377M |
| June 30, 2013 | 1.010M |
| March 31, 2013 | 1.735M |
| December 31, 2012 | 2.562M |
| September 30, 2012 | 3.056M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
4.989M
Minimum
Dec 2023
31.34M
Maximum
Mar 2021
14.75M
Average
9.160M
Median
Jun 2023
Shareholders Equity (Quarterly) Benchmarks
| Panbela Therapeutics Inc | -4.71M |
| Vera Therapeutics Inc | 101.68M |
| Corbus Pharmaceuticals Holdings Inc | -6.905M |
| Ensysce Biosciences Inc | -0.3229M |
| Elicio Therapeutics Inc | 11.37M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.787M |
| Total Liabilities (Quarterly) | 0.7975M |